Tyrosine kinases in rheumatoid arthritis
2011

Tyrosine Kinases in Rheumatoid Arthritis

publication Evidence: moderate

Author Information

Author(s): Okamoto Hiroshi, Kobayashi Akiko

Primary Institution: Minami-Otsuka Institute of Technology, Minami-Otsuka Clinic, Tokyo, Japan

Hypothesis

The review focuses on the role of tyrosine kinases in the pathogenesis of rheumatoid arthritis and the potential role of kinase inhibitors as new therapeutic strategies.

Conclusion

Tyrosine kinases play a significant role in the pathogenesis of rheumatoid arthritis, and targeting these kinases may offer new therapeutic strategies.

Supporting Evidence

  • Rheumatoid arthritis is characterized by inflammation and destruction of joints.
  • Tyrosine kinases are involved in the signaling pathways that regulate inflammatory responses in rheumatoid arthritis.
  • Many drugs targeting tyrosine kinases are currently in development for treating rheumatoid arthritis.

Takeaway

Rheumatoid arthritis is a disease where the body's immune system attacks its own joints, and scientists are looking at special proteins called tyrosine kinases to help find new treatments.

Methodology

This is a review article summarizing various studies on the role of tyrosine kinases in rheumatoid arthritis.

Potential Biases

The specificity of kinase inhibitors is questioned due to structural similarities among kinases, which may lead to off-target effects.

Limitations

The review discusses the lack of clinical efficacy and high rates of adverse events in trials targeting these kinases.

Digital Object Identifier (DOI)

10.1186/1476-9255-8-21

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication